Water-soluble prodrug of vitamin E for parenteral use and its effect on endotoxin-induced liver toxicity

Jiro Takata, Sanae Ito, Yoshiharu Karube, Yoshiko Itoh, Yoshikazu Matsushima

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The acid salts of aminoalkanecarboxylic acid esters of d-α-tocopherol were in a previous in vitro study identified as prodrug candidates for a parenteral form of d-α-tocopherol. The disposition of d-α-tocopheryl N,N- dimethylaminoacetate hydrochloride (TDMA), the most potential candidate for the prodrug, after a single intravenous administration was investigated and compared with that of the d-α-tocopheryl acetate (TA) and dl-α-tocopherol, solubilized with HCO-60, in order to establish the utility as a prodrug for i.v. administration. The preventive effect of the prodrug against endotoxin (lipopolysaccharide (LPS))-induced liver lipid peroxidation was also investigated in mice. The plasma and liver levels of α-tocopherol (Toc) were increased rapidly after i.v. administration of the prodrug. The distribution of Toc and TDMA in the plasma and the liver at I h was as follows; 2.1 ± 0.2 (plasma, Toc), 2.0 ± 0.2 (plasma, TDMA), 32.8 ± 2.9 (liver, Toc), and 35.3 ± 6.5% of dose (liver, TDMA). The rapid and liver-selective uptake and liver-esterase specific regeneration characteristics of the prodrug enhance the delivery of Toc to liver. The liver availability of Toc after i.v. administration of TDMA, TA and Toc were 116, 50 and 100%, respectively. The elevation of liver lipid peroxide induced with LPS was significantly suppressed to a normal range by a single i.v. postadministration of TDMA (over 10mg/kg equivalent for Toc). These results indicated that the water- soluble and liver-esterase hydrolyzable derivative of Toc was a potential candidate for a parenteral prodrug which can thus achieve the systemic liver- specific delivery of Toc. Such effective and selective delivery of Toc into the liver can therefore lead to enhanced pharmacological efficacy against liver oxidative injury associated with free radicals.

Original languageEnglish
Pages (from-to)204-209
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume20
Issue number2
Publication statusPublished - 1997 Feb

Fingerprint

Tocopherols
Prodrugs
Vitamin E
Endotoxins
Water
Liver
alpha-Tocopherol
Esterases
Lipopolysaccharides
Acids
Lipid Peroxides
Intravenous Administration
Lipid Peroxidation
Free Radicals
Regeneration

Keywords

  • d-α-tocopherol
  • endotoxin
  • lipid peroxidation
  • liver-specific delivery
  • vitamin E
  • water-soluble prodrug

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Water-soluble prodrug of vitamin E for parenteral use and its effect on endotoxin-induced liver toxicity. / Takata, Jiro; Ito, Sanae; Karube, Yoshiharu; Itoh, Yoshiko; Matsushima, Yoshikazu.

In: Biological and Pharmaceutical Bulletin, Vol. 20, No. 2, 02.1997, p. 204-209.

Research output: Contribution to journalArticle

Takata, Jiro ; Ito, Sanae ; Karube, Yoshiharu ; Itoh, Yoshiko ; Matsushima, Yoshikazu. / Water-soluble prodrug of vitamin E for parenteral use and its effect on endotoxin-induced liver toxicity. In: Biological and Pharmaceutical Bulletin. 1997 ; Vol. 20, No. 2. pp. 204-209.
@article{b5eda03648634cc78c2ca640890abcf3,
title = "Water-soluble prodrug of vitamin E for parenteral use and its effect on endotoxin-induced liver toxicity",
abstract = "The acid salts of aminoalkanecarboxylic acid esters of d-α-tocopherol were in a previous in vitro study identified as prodrug candidates for a parenteral form of d-α-tocopherol. The disposition of d-α-tocopheryl N,N- dimethylaminoacetate hydrochloride (TDMA), the most potential candidate for the prodrug, after a single intravenous administration was investigated and compared with that of the d-α-tocopheryl acetate (TA) and dl-α-tocopherol, solubilized with HCO-60, in order to establish the utility as a prodrug for i.v. administration. The preventive effect of the prodrug against endotoxin (lipopolysaccharide (LPS))-induced liver lipid peroxidation was also investigated in mice. The plasma and liver levels of α-tocopherol (Toc) were increased rapidly after i.v. administration of the prodrug. The distribution of Toc and TDMA in the plasma and the liver at I h was as follows; 2.1 ± 0.2 (plasma, Toc), 2.0 ± 0.2 (plasma, TDMA), 32.8 ± 2.9 (liver, Toc), and 35.3 ± 6.5{\%} of dose (liver, TDMA). The rapid and liver-selective uptake and liver-esterase specific regeneration characteristics of the prodrug enhance the delivery of Toc to liver. The liver availability of Toc after i.v. administration of TDMA, TA and Toc were 116, 50 and 100{\%}, respectively. The elevation of liver lipid peroxide induced with LPS was significantly suppressed to a normal range by a single i.v. postadministration of TDMA (over 10mg/kg equivalent for Toc). These results indicated that the water- soluble and liver-esterase hydrolyzable derivative of Toc was a potential candidate for a parenteral prodrug which can thus achieve the systemic liver- specific delivery of Toc. Such effective and selective delivery of Toc into the liver can therefore lead to enhanced pharmacological efficacy against liver oxidative injury associated with free radicals.",
keywords = "d-α-tocopherol, endotoxin, lipid peroxidation, liver-specific delivery, vitamin E, water-soluble prodrug",
author = "Jiro Takata and Sanae Ito and Yoshiharu Karube and Yoshiko Itoh and Yoshikazu Matsushima",
year = "1997",
month = "2",
language = "English",
volume = "20",
pages = "204--209",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "2",

}

TY - JOUR

T1 - Water-soluble prodrug of vitamin E for parenteral use and its effect on endotoxin-induced liver toxicity

AU - Takata, Jiro

AU - Ito, Sanae

AU - Karube, Yoshiharu

AU - Itoh, Yoshiko

AU - Matsushima, Yoshikazu

PY - 1997/2

Y1 - 1997/2

N2 - The acid salts of aminoalkanecarboxylic acid esters of d-α-tocopherol were in a previous in vitro study identified as prodrug candidates for a parenteral form of d-α-tocopherol. The disposition of d-α-tocopheryl N,N- dimethylaminoacetate hydrochloride (TDMA), the most potential candidate for the prodrug, after a single intravenous administration was investigated and compared with that of the d-α-tocopheryl acetate (TA) and dl-α-tocopherol, solubilized with HCO-60, in order to establish the utility as a prodrug for i.v. administration. The preventive effect of the prodrug against endotoxin (lipopolysaccharide (LPS))-induced liver lipid peroxidation was also investigated in mice. The plasma and liver levels of α-tocopherol (Toc) were increased rapidly after i.v. administration of the prodrug. The distribution of Toc and TDMA in the plasma and the liver at I h was as follows; 2.1 ± 0.2 (plasma, Toc), 2.0 ± 0.2 (plasma, TDMA), 32.8 ± 2.9 (liver, Toc), and 35.3 ± 6.5% of dose (liver, TDMA). The rapid and liver-selective uptake and liver-esterase specific regeneration characteristics of the prodrug enhance the delivery of Toc to liver. The liver availability of Toc after i.v. administration of TDMA, TA and Toc were 116, 50 and 100%, respectively. The elevation of liver lipid peroxide induced with LPS was significantly suppressed to a normal range by a single i.v. postadministration of TDMA (over 10mg/kg equivalent for Toc). These results indicated that the water- soluble and liver-esterase hydrolyzable derivative of Toc was a potential candidate for a parenteral prodrug which can thus achieve the systemic liver- specific delivery of Toc. Such effective and selective delivery of Toc into the liver can therefore lead to enhanced pharmacological efficacy against liver oxidative injury associated with free radicals.

AB - The acid salts of aminoalkanecarboxylic acid esters of d-α-tocopherol were in a previous in vitro study identified as prodrug candidates for a parenteral form of d-α-tocopherol. The disposition of d-α-tocopheryl N,N- dimethylaminoacetate hydrochloride (TDMA), the most potential candidate for the prodrug, after a single intravenous administration was investigated and compared with that of the d-α-tocopheryl acetate (TA) and dl-α-tocopherol, solubilized with HCO-60, in order to establish the utility as a prodrug for i.v. administration. The preventive effect of the prodrug against endotoxin (lipopolysaccharide (LPS))-induced liver lipid peroxidation was also investigated in mice. The plasma and liver levels of α-tocopherol (Toc) were increased rapidly after i.v. administration of the prodrug. The distribution of Toc and TDMA in the plasma and the liver at I h was as follows; 2.1 ± 0.2 (plasma, Toc), 2.0 ± 0.2 (plasma, TDMA), 32.8 ± 2.9 (liver, Toc), and 35.3 ± 6.5% of dose (liver, TDMA). The rapid and liver-selective uptake and liver-esterase specific regeneration characteristics of the prodrug enhance the delivery of Toc to liver. The liver availability of Toc after i.v. administration of TDMA, TA and Toc were 116, 50 and 100%, respectively. The elevation of liver lipid peroxide induced with LPS was significantly suppressed to a normal range by a single i.v. postadministration of TDMA (over 10mg/kg equivalent for Toc). These results indicated that the water- soluble and liver-esterase hydrolyzable derivative of Toc was a potential candidate for a parenteral prodrug which can thus achieve the systemic liver- specific delivery of Toc. Such effective and selective delivery of Toc into the liver can therefore lead to enhanced pharmacological efficacy against liver oxidative injury associated with free radicals.

KW - d-α-tocopherol

KW - endotoxin

KW - lipid peroxidation

KW - liver-specific delivery

KW - vitamin E

KW - water-soluble prodrug

UR - http://www.scopus.com/inward/record.url?scp=0030985739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030985739&partnerID=8YFLogxK

M3 - Article

C2 - 9057988

AN - SCOPUS:0030985739

VL - 20

SP - 204

EP - 209

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 2

ER -